Generation Bio Co.
GBIO · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.01 | -0.02 | 0.11 |
| FCF Yield | -80.59% | -105.42% | -22.85% | -11.91% |
| EV / EBITDA | -2.71 | -4.45 | -4.68 | -15.25 |
| Quality | ||||
| ROIC | -13.49% | -8.68% | -11.27% | -7.80% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 9.54 | 0.80 | 1.92 | 0.74 |
| Growth | ||||
| Revenue 3-Year CAGR | 71.52% | 188.95% | 2,906,504.05% | 2,709,422.84% |
| Free Cash Flow Growth | 39.57% | -77.00% | 17.70% | 8.87% |
| Safety | ||||
| Net Debt / EBITDA | -1.70 | -2.56 | -0.92 | -4.64 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 14.36 | 33.50 | 26.35 |